对参与者对松胺使用障碍psilocybin辅助心理治疗的期望和经验进行定性分析
Jonathan Brett1,2, Toby Lea3, Elizabeth Knock4
1St. Vincent's Clinical School Campus, University of New South Wales, Sydney, Australia.
Addiction (Abingdon, England)
|December 22, 2025
概括
松素辅助心理治疗 (PAT) 在治疗甲基胺使用障碍方面表现有前途. 参与者发现PAT是可以接受的,在面对挑战并得到强有力的治疗支持后,他们报告了新的自我理解和减少的渴望.
科学领域:
- 精神病学和成医学 医学
- 迷幻研究 迷幻研究
- 质量健康研究 质量健康研究
背景情况:
- 甲基胺使用障碍迫切需要创新的治疗方法.
- 目前正在探索以psilocybin辅助心理治疗 (PAT) 作为一种潜在的治疗干预.
研究的目的:
- 质量地探索因使用甲基胺障碍而接受PAT的个体的经验.
- 了解参与者对PAT的看法,包括它对物质使用,自我认知和人际关系的影响.
主要方法:
- 一项定性研究,涉及12名参与者在PAT的开放标签试点研究.
- 半结构面试是在PAT之前和一个月后进行的.
- 采访被分析使用一种诱导性定性方法.
主要成果:
- 参与者通常对PAT有现实的期望.
- 经历和面对具有挑战性的迷幻体验导致了新的自我理解和叙事洞察力.
- 一个关键的主题是"倾向于障碍物",与减少甲基胺突出相关.
- 强大的治疗联盟,以关注和亲密为特征,对于积极的结果至关重要.
结论:
- 参与者认为psilocybin辅助心理治疗 (PAT) 是对甲基胺使用障碍的可接受治疗方法.
- 自我认知和人际关系的转变,通过在支持性的治疗环境中面对挑战来促进,与减少的甲基胺使用有关.
- 这些发现突显了PAT的潜力,强调了治疗联盟和"倾向于障碍物"机制的作用.
相关概念视频
CNS Stimulants: Psychedelic Agents
637
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
637
Altered States of Awareness
958
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
958
Hallucinogens and Psychedelics
564
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
564
Elements Crucial for Effective Psychotherapy
306
Research has highlighted several critical factors that influence the effectiveness of psychotherapy, such as the therapeutic alliance, the therapist, and the client.
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
306
Group Therapy
336
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
336
Psychosis: Goals of Pharmacotherapy
441
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
441


